Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| type II pneumocyte | 5 studies | 39% ± 8% | |
| fibroblast | 4 studies | 22% ± 5% |
Insufficient scRNA-seq data for expression of PTGFR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 79% | 512.74 | 203 / 258 | 73% | 9.32 | 168 / 230 |
| breast | 94% | 1474.24 | 432 / 459 | 43% | 1.89 | 480 / 1118 |
| bladder | 95% | 1797.00 | 20 / 21 | 33% | 1.21 | 166 / 504 |
| skin | 97% | 1998.98 | 1751 / 1809 | 27% | 0.97 | 129 / 472 |
| uterus | 96% | 1757.01 | 163 / 170 | 28% | 2.58 | 128 / 459 |
| kidney | 67% | 307.88 | 60 / 89 | 42% | 2.53 | 380 / 901 |
| prostate | 48% | 328.48 | 117 / 245 | 55% | 3.39 | 274 / 502 |
| intestine | 62% | 381.64 | 603 / 966 | 36% | 0.98 | 192 / 527 |
| lung | 55% | 273.88 | 319 / 578 | 38% | 1.55 | 441 / 1155 |
| adipose | 87% | 1502.14 | 1048 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 38% | 278.89 | 138 / 359 | 48% | 1.51 | 136 / 286 |
| esophagus | 55% | 664.72 | 799 / 1445 | 31% | 1.05 | 56 / 183 |
| ovary | 78% | 465.09 | 141 / 180 | 7% | 0.19 | 32 / 430 |
| blood vessel | 79% | 932.31 | 1058 / 1335 | 0% | 0 | 0 / 0 |
| liver | 21% | 82.46 | 47 / 226 | 47% | 5.93 | 191 / 406 |
| pancreas | 8% | 30.93 | 27 / 328 | 60% | 1.90 | 106 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 52% | 1.18 | 15 / 29 |
| muscle | 37% | 223.13 | 301 / 803 | 0% | 0 | 0 / 0 |
| brain | 7% | 40.42 | 195 / 2642 | 25% | 1.06 | 178 / 705 |
| thymus | 28% | 141.23 | 186 / 653 | 3% | 0.04 | 16 / 605 |
| heart | 26% | 124.68 | 225 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 18% | 0.34 | 8 / 45 |
| spleen | 1% | 6.68 | 3 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 2.40 | 7 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0032355 | Biological process | response to estradiol |
| GO_0071799 | Biological process | cellular response to prostaglandin D stimulus |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0006954 | Biological process | inflammatory response |
| GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
| GO_0032496 | Biological process | response to lipopolysaccharide |
| GO_0007567 | Biological process | parturition |
| GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0004958 | Molecular function | prostaglandin F receptor activity |
| Gene name | PTGFR |
| Protein name | Prostaglandin F2-alpha receptor (PGF receptor) (PGF2-alpha receptor) (Prostanoid FP receptor) Prostanoid FP receptor Prostaglandin F2-alpha receptor (Prostanoid FP receptor) |
| Synonyms | |
| Description | FUNCTION: Receptor for prostaglandin F2-alpha (PGF2-alpha). The activity of this receptor is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. Initiates luteolysis in the corpus luteum (By similarity). Isoforms 2 to 7 do not bind PGF2-alpha but are proposed to modulate signaling by participating in variant receptor complexes; heterodimers between isoform 1 and isoform 5 are proposed to be a receptor for prostamides including the synthetic analog bimatoprost. . |
| Accessions | ENST00000370757.8 [P43088-1] ENST00000370758.5 [P43088-1] ENST00000497923.5 F2Z2Z6 Q4LEK1 ENST00000370756.3 [P43088-2] Q71UN9 P43088 |